Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220004617 220001833 1.45 null null 2016-09-12 2016-09-12 Cytarabine Low Dose N N 220026427 CYTARABINE
220004618 220021698 1.67 null Curative (C) 2014-09-28 2014-10-10 Trial Unspecified 01 N 220026437 TRIAL
220004619 220021698 null null Disease modification (D) 2013-03-28 2013-03-28 CYTARABINE N N 220026437 CYTARABINE
220004620 220001834 1.73 67.55 Disease modification (D) 2016-01-19 2016-02-02 Cytarabine Low Dose 02 N 220026446 CYTARABINE
220004621 220010931 1.56 116 null 2014-10-24 2014-10-25 AML17 TRIAL 1 N 220026447 AML17 TRIAL
220004623 220001836 1.73 61.1 Palliative (P) 2016-06-03 2016-06-03 Trial Unspecified 01 null 220026453 TRIAL
220004624 220010932 1.65 91.1 Palliative (P) 2017-08-27 2017-08-28 Trial Unspecified Y null 220026455 TRIAL
220004625 220010932 1.77 98 Disease modification (D) 2015-07-22 2015-07-22 Cytarabine Low Dose 02 N 220026455 CYTARABINE
220004626 220001837 1.6 null Curative (C) 2013-05-28 2013-05-29 AML17 TRIAL 02 N 220026461 AML17 TRIAL
220004627 220001837 1.82 70.6 Curative (C) 2016-11-12 2016-11-16 AML17 TRIAL 01 N 220026461 AML17 TRIAL
220004628 220001838 1.69 81.6 Curative (C) 2016-05-25 2016-05-25 AML17 TRIAL N N 220026466 AML17 TRIAL
220004629 220001839 1.6 67.5 Not known (9) 2017-03-11 2017-03-16 AML17 TRIAL Y N 220026469 AML17 TRIAL
220004630 220001839 null 40.9 Palliative (P) 2013-10-23 2013-10-23 AML17 TRIAL 1 N 220026469 AML17 TRIAL
220004631 220001840 1.62 null Disease modification (D) 2014-07-12 2014-08-14 Trial Unspecified Y N 220026472 TRIAL
220004632 220001840 1.72 79.5 Palliative (P) 2013-03-02 2013-03-03 LI-1 TRIAL 01 null 220026472 TRIAL
220004633 220001840 1.6 null Curative (C) 2017-11-25 2017-11-28 Trial Unspecified 1 null 220026472 TRIAL
220004634 220001840 1.73 58 Palliative (P) 2015-02-26 2015-02-27 Cytarabine Low Dose N N 220026472 CYTARABINE
220004635 220001841 1.72 57 Curative (C) 2014-12-10 2014-12-11 AML17 TRIAL N N 220026483 AML17 TRIAL
220004636 220001841 1.75 69 null null 2014-01-29 Trial Unspecified Y N 220026483 TRIAL
220004637 220001841 1.7 0 null 2018-01-03 2018-01-16 Cytarabine Low Dose N N 220026483 CYTARABINE
220004638 220001841 1.72 63 Palliative (P) 2015-10-13 2015-11-09 Cytarabine low (10to20mg/m2) IV/SC N N 220026483 CYTARABINE
220004639 220001841 1.77 null Disease modification (D) 2015-12-03 2015-12-11 Trial Unspecified 1 null 220026483 TRIAL
220004640 220001842 1.8 86.5 Curative (C) 2013-12-21 2013-12-21 Trial Unspecified 1 N 220026491 TRIAL
220004641 220010937 null null Curative (C) 2017-11-23 2017-11-23 AML17 TRIAL Y N 220026492 AML17 TRIAL
220004642 220001843 1.53 null Palliative (P) 2015-04-20 2015-04-23 Cytarabine low (10to20mg/m2) IV/SC N N 220026494 CYTARABINE
220004643 220010938 1.74 106.6 Not known (9) 2016-06-28 2016-07-02 AML17 TRIAL Y N 220026496 AML17 TRIAL
220004644 220010938 null 56 Palliative (P) 2013-05-13 2013-05-17 Trial Unspecified Y N 220026496 TRIAL
220004654 220001844 1.64 null Disease modification (D) null 2015-02-20 Cytarabine Low Dose 02 N 220026517 CYTARABINE
220004655 220001844 1.67 86.8 null 2017-03-04 2017-03-12 Cytarabine Low Dose 2 N 220026517 CYTARABINE
220004656 220001845 1.82 null Curative (C) 2016-04-29 2016-04-29 Trial Unspecified 01 N 220026519 TRIAL
220004657 220001846 1.78 57.5 null 2014-05-17 2014-05-17 CYTARABINE 2 N 220026523 CYTARABINE
220004658 220001847 0 96.2 Not known (9) null 2014-01-31 AML17 TRIAL 02 null 220026524 AML17 TRIAL
220004659 220001847 1.7 50 Curative (C) 2013-03-03 2013-03-05 AML17 TRIAL 1 null 220026524 AML17 TRIAL
220004660 220015838 null null Disease modification (D) 2015-07-22 2015-07-22 Cytarabine Low Dose N N 220026526 CYTARABINE
220004661 220001848 null 73.2 Curative (C) 2016-09-08 2016-09-08 AML17 TRIAL Y N 220026530 AML17 TRIAL
220004662 220001849 1.66 null Curative (C) 2017-07-04 2017-07-05 AML17 TRIAL Y N 220026531 AML17 TRIAL
220004663 220001849 1.69 116 Curative (C) 2013-11-24 2013-11-26 AML17 TRIAL Y N 220026531 AML17 TRIAL
220004664 220015839 1.56 58 Curative (C) null 2017-06-18 AML17 TRIAL N N 220026534 AML17 TRIAL
220004665 220015839 1.83 null Curative (C) 2017-12-03 2017-12-03 Trial Unspecified null null 220026534 TRIAL
220004666 220001850 1.77 0 Disease modification (D) 2015-10-10 2015-10-23 Cytarabine Low Dose 2 N 220026539 CYTARABINE
220004667 220010942 1.81 59 Curative (C) 2014-11-15 2014-11-15 LI-1 TRIAL Y N 220026542 TRIAL
220004668 220001851 null null Curative (C) null 2015-11-15 Trial Unspecified null null 220026546 TRIAL
220004669 220001851 1.64 null Curative (C) 2015-10-13 2015-10-16 Cytarabine Low Dose N N 220026546 CYTARABINE
220004670 220001852 1.76 104.7 Curative (C) 2017-03-07 2017-03-09 Trial Unspecified Y N 220026551 TRIAL
220004671 220010944 1.62 0 null 2018-02-13 2018-02-13 Cytarabine Low Dose N N 220026553 CYTARABINE
220004672 220001853 1.69 98.2 Palliative (P) 2013-03-24 2013-03-24 CYTARABINE null null 220026554 CYTARABINE
220004673 220001853 1.91 45 null 2013-02-21 2013-02-24 Cytarabine Low Dose 02 N 220026554 CYTARABINE
220004677 220001855 0 93.1 null 2017-08-17 2017-08-17 AML17 TRIAL null N 220026569 AML17 TRIAL
220004678 220001856 1.44 91 Not known (9) 2017-08-27 2017-09-02 AML17 TRIAL N N 220026570 AML17 TRIAL
220004679 220001856 null 62 Curative (C) 2016-11-18 2016-11-18 AML17 TRIAL N N 220026570 AML17 TRIAL